{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T04:05:36Z","timestamp":1746158736822,"version":"3.40.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["medical-hypotheses.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.mehy.2013.12.007","type":"journal-article","created":{"date-parts":[[2013,12,21]],"date-time":"2013-12-21T10:15:58Z","timestamp":1387620958000},"page":"266-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Is rheumatoid arthritis a B-cell haematological disease with a predilection for the joints? Following the B cell thread to its logical conclusion"],"prefix":"10.1016","volume":"82","author":[{"given":"Fiona M.","family":"McQueen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samar","family":"Issa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mehy.2013.12.007_b0005","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.coi.2008.05.011","article-title":"Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies","volume":"20","author":"Taylor","year":"2008","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10.1016\/j.mehy.2013.12.007_b0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1517\/14740330902750114","article-title":"Ten years of rituximab in NHL","volume":"8","author":"Winter","year":"2009","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"10.1016\/j.mehy.2013.12.007_b0015","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/annonc\/mdl467","article-title":"Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases","volume":"18","author":"Wohrer","year":"2007","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.mehy.2013.12.007_b0020","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrrheum.2011.62","article-title":"Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma","volume":"7","author":"Dias","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"17","key":"10.1016\/j.mehy.2013.12.007_b0025","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.mehy.2013.12.007_b0030","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1200\/JCO.2010.29.8711","article-title":"Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies","volume":"29","author":"Tefferi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.mehy.2013.12.007_b0035","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.mehy.2009.03.050","article-title":"Will Jill come tumbling after? The case for a JAK2-type mutation as a prequel to the connective tissue disorders","volume":"73","author":"McQueen","year":"2009","journal-title":"Med Hypotheses"},{"issue":"9","key":"10.1016\/j.mehy.2013.12.007_b0040","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.humpath.2007.02.009","article-title":"Bone marrow trephines containing lymphoid aggregates from patients with rheumatoid and other autoimmune disorders frequently show clonal B-cell infiltrates","volume":"38","author":"Engels","year":"2007","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.mehy.2013.12.007_b0045","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/art.27767","article-title":"V-region gene analysis of locally defined synovial B and plasma cells reveals selected B cell expansion and accumulation of plasma cell clones in rheumatoid arthritis","volume":"63","author":"Scheel","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.mehy.2013.12.007_b0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/03009740310000346","article-title":"Clonal analysis of B cells in the synovial membrane of patients with rheumatoid arthritis","volume":"32","author":"Shiokawa","year":"2003","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.mehy.2013.12.007_b0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/ar4115","article-title":"Inflammatory lesions in the bone marrow of rheumatoid arthritis patients: a morphological perspective","volume":"14","author":"Bugatti","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.mehy.2013.12.007_b0060","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1371\/journal.pmed.0060001","article-title":"Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium","volume":"6","author":"Humby","year":"2009","journal-title":"PLoS Med\/Pub Library Sci"},{"issue":"14","key":"10.1016\/j.mehy.2013.12.007_b0065","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1200\/JCO.2010.32.8435","article-title":"Molecular heterogeneity of multiple myeloma: pathogenesis, prognosis, and therapeutic implications","volume":"29","author":"Herve","year":"2011","journal-title":"J Clin Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.mehy.2013.12.007_b0070","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1080\/10428190310001621588","article-title":"Molecular pathogenesis of non-Hodgkin\u2019s lymphoma: the role of Bcl-6","volume":"44","author":"Pasqualucci","year":"2003","journal-title":"Leuk Lymphoma"},{"issue":"16","key":"10.1016\/j.mehy.2013.12.007_b0075","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus [see comment]","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.mehy.2013.12.007_b0080","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"16","key":"10.1016\/j.mehy.2013.12.007_b0085","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2013.12.007_b0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-065X.1998.tb01220.x","article-title":"B-cell epitope spreading in autoimmunity","volume":"164","author":"James","year":"1998","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.mehy.2013.12.007_b0095","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaut.2010.06.016","article-title":"B-cell epitopes of the intracellular autoantigens Ro\/SSA and La\/SSB: tools to study the regulation of the autoimmune response","volume":"35","author":"Routsias","year":"2010","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.mehy.2013.12.007_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/icb.1972.1","article-title":"A reassessment of the forbidden clone hypothesis of autoimmune disease","volume":"50","author":"Burnet","year":"1972","journal-title":"Aust J Exp Biol Med Sci"},{"key":"10.1016\/j.mehy.2013.12.007_b0105","doi-asserted-by":"crossref","DOI":"10.1136\/postgradmedj-2011-130364","article-title":"A B cell explanation for autoimmune disease: the forbidden clone returns","author":"McQueen","year":"2012","journal-title":"Postgrad Med J"},{"issue":"5638","key":"10.1016\/j.mehy.2013.12.007_b0110","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.1086907","article-title":"Predominant autoantibody production by early human B cell precursors","volume":"301","author":"Wardemann","year":"2003","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.mehy.2013.12.007_b0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/ard.15.3.217","article-title":"Nature of anaemia in rheumatoid arthritis. III. Changes in the bone marrow and their relation to other features of the disease","volume":"15","author":"Duthie","year":"1956","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.mehy.2013.12.007_b0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0","article-title":"Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis","volume":"44","author":"Reparon-Schuijt","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.mehy.2013.12.007_b0125","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/ard.2008.096024","article-title":"Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease","volume":"68","author":"Dalbeth","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.mehy.2013.12.007_b0130","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1136\/ard.2007.070326","article-title":"High grade MRI bone oedema is common within the surgical field in rheumatoid arthritis patients undergoing joint replacement and is associated with osteitis in subchondral bone","volume":"66","author":"McQueen","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.mehy.2013.12.007_b0135","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1186\/ar1737","article-title":"B cells in rheumatoid synovitis","volume":"7","author":"Weyand","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.mehy.2013.12.007_b0140","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/ar4035","article-title":"Bone marrow edema and osteitis in rheumatoid arthritis: the imaging perspective","volume":"14","author":"McQueen","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.mehy.2013.12.007_b0145","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/art.11162","article-title":"Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis","volume":"48","author":"McQueen","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mehy.2013.12.007_b0150","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/ard.2007.071977","article-title":"Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression","volume":"67","author":"Haavardsholm","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.mehy.2013.12.007_b0155","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/ard.2009.125534","article-title":"Radiographic progression and remission rates in early rheumatoid arthritis \u2013 MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial","volume":"69","author":"Hetland","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.mehy.2013.12.007_b0160","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","article-title":"Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin","volume":"122","author":"Harre","year":"2012","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.mehy.2013.12.007_b0165","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","article-title":"Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment","volume":"8","author":"Schett","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.mehy.2013.12.007_b0170","article-title":"Impact of anti tumor necrosis factor-alpha therapy in rheumatoid arthritis on osteoclast activation and B cells","volume":"42","author":"Ezealah","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.mehy.2013.12.007_b0175","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/ajcp\/112.6.836","article-title":"Precursor B lymphoblastic lymphoma presenting as lytic bone lesions","volume":"112","author":"Iravani","year":"1999","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.mehy.2013.12.007_b0180","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2141.2007.06866.x","article-title":"Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseases","volume":"139","author":"Landgren","year":"2007","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.mehy.2013.12.007_b0185","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/rheumatology\/keq419","article-title":"The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis","volume":"50","author":"Van Steendam","year":"2011","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.mehy.2013.12.007_b0190","first-page":"991","article-title":"Predictors of response to rituximab in patients with active rheumatoid arthritis and inadequate response to anti-TNF agents or traditional DMARDs","volume":"29","author":"Narvaez","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"25","key":"10.1016\/j.mehy.2013.12.007_b0195","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [see comment]","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.mehy.2013.12.007_b0200","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrrheum.2011.79","article-title":"Rheumatoid arthritis: when should we use rituximab to treat RA?","volume":"7","author":"Yazici","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.mehy.2013.12.007_b0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/rheumatology\/kel148","article-title":"Bone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapy","volume":"46","author":"Leandro","year":"2007","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.mehy.2013.12.007_b0210","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/ard.2007.085787","article-title":"Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies","volume":"68","author":"Keystone","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.mehy.2013.12.007_b0215","article-title":"Rituximab (RTX) plus methotrexate (MTX) prevents bone erosion and joint space narrowing (jsn) and reduces synovitis, osteitis as shown on MRI: results from a randomised, placebo-controlled clinical trial on patients with rheumatoid arthritis (RA-score)","volume":"70","author":"Peterfy","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.mehy.2013.12.007_b0220","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/ard.61.10.883","article-title":"Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion","volume":"61","author":"Leandro","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.mehy.2013.12.007_b0225","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.30445","article-title":"Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1\u22170401-positive humanized mice and rheumatoid arthritis patients","volume":"63","author":"Snir","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.mehy.2013.12.007_b0230","first-page":"491","article-title":"Is B-cell the conductor of the lymphocyte orchestra in the salivary glands of patients with primary Sjogren\u2019s syndrome","volume":"24","author":"Youinou","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.mehy.2013.12.007_b0235","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3816\/CLM.2005.n.036","article-title":"Monoclonal gammopathy of undetermined significance","volume":"6","author":"Kyle","year":"2005","journal-title":"Clin Lymphoma Myeloma"},{"issue":"11","key":"10.1016\/j.mehy.2013.12.007_b0240","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3109\/10428194.2010.513750","article-title":"Long-term response to maintenance treatment with rituximab in CD20(+) multiple myeloma","volume":"51","author":"Ohno","year":"2010","journal-title":"Leuk Lymphoma"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713005914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987713005914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T08:36:59Z","timestamp":1746088619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987713005914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0306987713005914"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2013.12.007","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is rheumatoid arthritis a B-cell haematological disease with a predilection for the joints? Following the B cell thread to its logical conclusion","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2013.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}